Evidence Rounds
@evidencerounds.bsky.social
News you can use in hospital medicine
Medical literature is doubling rapidly, but knowledge isn't. Too many studies fail to answer the questions that matter most. We find and appraise the rare practice-changing evidence and cutting edge ideas.
Medical literature is doubling rapidly, but knowledge isn't. Too many studies fail to answer the questions that matter most. We find and appraise the rare practice-changing evidence and cutting edge ideas.
November 20, 2025 at 8:15 PM
Outcomes were similar whether or not patients met the K target
ECG intervals didn’t differ
The small reduction in arrhythmia hospitalizations was delayed, despite immediate K separation between groups
ECG intervals didn’t differ
The small reduction in arrhythmia hospitalizations was delayed, despite immediate K separation between groups
November 19, 2025 at 7:00 PM
Outcomes were similar whether or not patients met the K target
ECG intervals didn’t differ
The small reduction in arrhythmia hospitalizations was delayed, despite immediate K separation between groups
ECG intervals didn’t differ
The small reduction in arrhythmia hospitalizations was delayed, despite immediate K separation between groups
In a ‘positive’ trial of targeting K 4.5–5 for outpatients with ICDs, many were newly started on MRAs
A subgroup analysis suggested they drove the benefit
A subgroup analysis suggested they drove the benefit
November 19, 2025 at 7:00 PM
In a ‘positive’ trial of targeting K 4.5–5 for outpatients with ICDs, many were newly started on MRAs
A subgroup analysis suggested they drove the benefit
A subgroup analysis suggested they drove the benefit
Waymo safety data here
More rigorous research needed, but it's the most promising solution to date
#EvidenceRounds
#Surgery
#HealthPolicy
More rigorous research needed, but it's the most promising solution to date
#EvidenceRounds
#Surgery
#HealthPolicy
Safety Impact
We're voluntarily sharing our safety data to demonstrate how the Waymo Driver is making roads safer in the places we currently operate. See the stats.
waymo.com
November 16, 2025 at 4:08 PM
Waymo safety data here
More rigorous research needed, but it's the most promising solution to date
#EvidenceRounds
#Surgery
#HealthPolicy
More rigorous research needed, but it's the most promising solution to date
#EvidenceRounds
#Surgery
#HealthPolicy
Prevalence & clinical manifestations of VEXAS
#EvidenceRounds
#Rheumatology
#Hematology
#Diagnosis
#GeneralMedicine
jamanetwork.com/jour...
#EvidenceRounds
#Rheumatology
#Hematology
#Diagnosis
#GeneralMedicine
jamanetwork.com/jour...
November 12, 2025 at 4:41 PM
Prevalence & clinical manifestations of VEXAS
#EvidenceRounds
#Rheumatology
#Hematology
#Diagnosis
#GeneralMedicine
jamanetwork.com/jour...
#EvidenceRounds
#Rheumatology
#Hematology
#Diagnosis
#GeneralMedicine
jamanetwork.com/jour...
Summary of VEXAS
Discovering VEXAS
A newly discovered disease, called VEXAS, can appear suddenly in midlife. It can cause symptoms like fevers, rashes, or fatigue. Scientists are looking into why it starts and how to treat it.
newsinhealth.nih.gov
November 12, 2025 at 4:40 PM
Summary of VEXAS
Two examples of many cohort studies showing decreased survival among ICI treated patients with NSCLC and ECOG 2+ status in practice
#EvidenceRounds
#Oncology
#GeneralMedicine
www.nejm.org/doi/10....
pmc.ncbi.nlm.nih.gov...
#EvidenceRounds
#Oncology
#GeneralMedicine
www.nejm.org/doi/10....
pmc.ncbi.nlm.nih.gov...
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer | NEJM
Pembrolizumab is a humanized monoclonal antibody against programmed death 1 (PD-1)
that has antitumor activity in advanced non–small-cell lung cancer (NSCLC), with increased
activity in tumors that...
www.nejm.org
November 9, 2025 at 4:25 PM
Two examples of many cohort studies showing decreased survival among ICI treated patients with NSCLC and ECOG 2+ status in practice
#EvidenceRounds
#Oncology
#GeneralMedicine
www.nejm.org/doi/10....
pmc.ncbi.nlm.nih.gov...
#EvidenceRounds
#Oncology
#GeneralMedicine
www.nejm.org/doi/10....
pmc.ncbi.nlm.nih.gov...
November 9, 2025 at 4:25 PM